Fabry disease represents a complex lysosomal storage disorder stemming from GLA gene alterations resulting in alpha-galactosidase A enzyme deficiency. This metabolic disruption generates toxic lipid accumulation, primarily globotriaosylceramide (Gb3), causing progressive organ deterioration throughout renal, cardiac, and neurological systems while profoundly compromising patient survival...